Arquivamento definitivo - Art. 33 da LPI
#11.1.1
01/06/2026
RPI 2870
Application data
Number
112024006701Type
Filing
Publication
PCT
US2022046094 The application was abandoned: examination was not requested within the 36 months following the 10/07/2022 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 01/06/2026. We update with every new RPI gazette, published weekly.
Applicants
X4 PHARMACEUTICALS, INC.
US
Inventors
K. B. (pessoa física)
IT
R. H. (pessoa física)
US
IPC Classification
Priority claims
US
63/262,225 · 10/07/2021
Abstract
SÍNTESE DE MAVORIXAFOR E INTERMEDIÁRIOS DO MESMO. A presente invenção refere-se aos métodos para sintetizar o inibidor do receptor C-X-C tipo 4 (CXCR4), mavorixafor e aos intermediários do mesmo.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
01/06/2026
RPI 2870
#11.1
10/14/2025
RPI 2858
#1.3
07/09/2024
RPI 2792
#1.1
04/16/2024
RPI 2780
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.